ClinicalTrials.Veeva

Menu

Impact of Renal Replacement Therapy on Coagulation Profile of Patients with Acute Renal Failure (HEMOSTIR)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Hemorrhage
Coagulation Disorder
Acute Renal Failure

Study type

Observational

Funder types

Other

Identifiers

NCT03536195
HEMOSTIR (29BRC17.0132)

Details and patient eligibility

About

Renal failure and high plasmatic level of urea have been associated with an increased risk of hemorrhage in surgical patients. There is only sparse data on the impact of renal replacement therapy on homeostatic parameters. The aim of this study is to describe potential changes in homeostatic parameters before and after renal replacement therapy.

Enrollment

14 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • critically ill patients
  • acute renal failure
  • renal replacement therapy
  • plasmatic urea > 20

Exclusion criteria

  • chronic renal failure
  • platelet count less than 80 Giga
  • V factor less than 70%

Trial contacts and locations

1

Loading...

Central trial contact

Cécile AUBRON

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems